Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Cary Pharmaceuticals
Life After White Oak: Hamburg’s Predecessors Offer Glimpse At Where Pharma Might See Her Again
In interviews with “The Pink Sheet,” the last half-dozen FDA commissioners discuss crafting policy on Capitol Hill, building start-up biotechs, consulting and serving on industry boards.
Mind over matter - depression: the ups and downs of a troubled pipeline
Depression is one of the most difficult CNS diseases to diagnose and treat. Despite this significant unmet need, the development of new products is frustratingly slow. We review the latest progress in this area.
Deals Shaping the Medical Industry (3/06)
The dealmaking column is a survey of recent transactions, including strategic alliances, mergers & acquisitions, and financings, in the life sciences industries. Deals are listed by the following industry sectors: in vitro diagnostics, pharmaceuticals, medical devices, and research/analytical instrumentation and reagents. All transactions are excerpted from Windhover's Strategic Transactions database, providing comprehensive transaction coverage from 1991 to the present.
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.